New Taipei City, Taiwan, Nov. 24, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced that the Company has entered into a non‑binding letter of intent (the “LOI”) wit ...

New Taipei City, Taiwan, Nov. 20, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced that it has achieved another milestone in the development of its plant-derived n ...

Group 1 - The top five gainers among Chinese concept stocks include Kuke Music with a rise of 263.64%, Meiyantang with 34.69%, Wangsu Technology with 33.89%, Jian Yong Biotechnology with 24.46%, and Haodingduo with 13.47% [1] - Kuke Music's latest price is 0.0500, with a gain of 0.0363 and a trading volume of 1840.56 thousand [1] - Meiyantang's latest price is 19.140, with a gain of 4.930 and a trading volume of 10.7747 million [1] - Wangsu Technology's latest price is 8.770, with a gain of 2.220 and a trading volume of 2.6759 million [1] - Jian Yong Biotechnology's latest price is 50.020, with a gain of 9.830 and a trading volume of 10.2408 million [1] - Haodingduo's latest price is 3.960, with a gain of 0.470 and a trading volume of 10.7239 million [1]

Group 1 - The top five Chinese concept stocks that experienced the largest declines in closing prices are: Wisdom Logistics down 71.18%, Haodingduo down 34.97%, Jiuzixineng down 20.83%, Jian Yong Biotechnology down 17.76%, and Shangao Life Sciences down 15.97% [1] - Wisdom Logistics (SLGB) closed at 3.000 with a decrease of 41.18%, translating to a drop of 2.100, with a trading volume of 36.8617 million [1] - Haodingduo (MAMK) closed at 3.440, down 34.97%, which is a decrease of 1.850, with a trading volume of 36.2105 million [1] - Jiuzixineng (JZXN) closed at 0.2881, down 20.83%, reflecting a decrease of 0.0758, with a trading volume of 39.3645 million [1] - Jian Yong Biotechnology (MENS) closed at 50.000, down 17.76%, which is a drop of 10.800, with a trading volume of 27.0842 million [1] - Shangao Life Sciences (TATA) closed at 1.000, down 15.97%, translating to a decrease of 0.190, with a trading volume of 613.22 thousand [1]

New Taipei City, Taiwan, Sept. 29, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company” or “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced that its subsidiary, Health Ever Bio-Tech Co., Ltd., has been honored with the ...

New Taipei City, Taiwan, Sept. 18, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced that its chairwoman and chief executive officer, Fu Feng Kuo, has been invited to ...

New Taipei City, Taiwan, Sept. 16, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the “Company”, “Jyong Biotech”), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, today announced that it has completed patient enrollment in its Phase II clinical trial of MCS‑8, ...

New Taipei City, Taiwan, Aug. 22, 2025 (GLOBE NEWSWIRE) -- Jyong Biotech Ltd. (Nasdaq: MENS) (the "Company", "Jyong Biotech"), a science-driven biotechnology company based in Taiwan committed to developing and commercializing innovative and differentiated new drugs (plant-derived) mainly specializing in the treatment of urinary system diseases, with an initial focus on the markets of the U.S., the EU and Asia, announced its participation in the 22 Urological Association of Asia Congress which was held in co ...

Group 1 - The top five Chinese concept stocks that experienced the largest declines in closing prices are Mint, e家快服, 健永生技, AirNet Technology, and 天演药业, with declines of 33.18%, 21.15%, 18.46%, 17.77%, and 16.59% respectively [1] - Mint's latest price is 5.660, with a drop of 2.810 and a trading volume of 17.6069 million [1] - e家快服's latest price is 1.100, with a decrease of 0.295 and a trading volume of 514.7 thousand [1] - 健永生技's latest price is 40.410, with a decline of 9.150 and a trading volume of 13.7547 million [1] - AirNet Technology's latest price is 2.800, with a drop of 0.605 and a trading volume of 196.45 thousand [1] - 天演药业's latest price is 1.910, with a decrease of 0.380 and a trading volume of 33.98 thousand [1]

Group 1 - The article does not provide any specific company or industry analysis, focusing instead on the author's qualifications and disclosures [1][2][3]